Literature DB >> 23329719

First reported case of posterior reversible encephalopathy syndrome occurring in a weightlifter.

Ryan Strzelecki1, Anil Ramlackhansingh, Tom Baldwin, Stephen Sturman.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is an increasingly well recognised clinical and radiological condition. Here we report on the first known published case of PRES in a weightlifter. We present a 34-year-old man with acute onset visual disturbance and expressive dysphasia which occurred after an intensive gym session.

Entities:  

Mesh:

Year:  2013        PMID: 23329719      PMCID: PMC3604522          DOI: 10.1136/bcr-2012-007902

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

2.  Middle cerebral artery blood velocity during intense static exercise is dominated by a Valsalva maneuver.

Authors:  Frank Pott; Johannes J Van Lieshout; Kojiro Ide; Per Madsen; Niels H Secher
Journal:  J Appl Physiol (1985)       Date:  2002-11-15

3.  Arterial blood pressure response to heavy resistance exercise.

Authors:  J D MacDougall; D Tuxen; D G Sale; J R Moroz; J R Sutton
Journal:  J Appl Physiol (1985)       Date:  1985-03

Review 4.  The posterior reversible encephalopathy syndrome: what's certain, what's new?

Authors:  C Roth; A Ferbert
Journal:  Pract Neurol       Date:  2011-06

5.  Posterior reversible encephalopathy syndrome in a case of postoperative spinal extradural haematoma: case report and review of literature.

Authors:  Chittur Viswanathan Gopalakrishnan; Vazhayil Vikas; Suresh Nair
Journal:  Asian Spine J       Date:  2011-03-02

Review 6.  Posterior leukoencephalopathy syndrome.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2001-01       Impact factor: 2.401

7.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.